Sign in

CIK 0000768408 · Non-accelerated filer<br>Smaller reporting company

CYANOTECH CORP

Sign in to watch
Ticker
CYAN
Exchange
OTC
Industry
Medicinal Chemicals & Botanical Products
FY end
Mar 31
Incorporated
NV
Entity type
operating
EIN
911206026
Phone
8083261353
Business address
73-4460 QUEEN KAAHUMANU HWY, SUITE 102, KAILUA KONA, HI, 96740
  1. 10-Q Report Quarterly Report
  2. SC 13D/A Stake Beneficial Ownership Report
  3. 4 Open-market buy Director bought 5,000 shares at $0.76 ($3,800)
  4. 4 Open-market buy Director bought 10,000 shares at an average $0.77 ($7,650)
  5. 4 Open-market buy Director bought 10,000 shares at $0.77 ($7,700)
  6. 4 Open-market buy Director bought 10,000 shares at an average $0.75 ($7,500)
  7. 4 Open-market buy Director bought 10,000 shares at an average $0.76 ($7,550)
  8. 4 Open-market buy Director bought 10,000 shares at an average $0.76 ($7,580)
  9. 4 Open-market buy Director bought 10,000 shares at $0.82 ($8,200)
  10. 4 Open-market buy Director bought 10,000 shares at $0.83 ($8,300)
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 4 Open-market buy Director bought 10,000 shares at an average $0.84 ($8,350)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Director bought 10,000 shares at $0.84 ($8,400)
  16. SC 13D/A Stake Beneficial Ownership Report
  17. 4 Grant or award Director acquired 39,506 shares (grant or award)
  18. 4 Grant or award Director acquired 39,506 shares (grant or award)
  19. 4 Open-market buy Director bought 10,000 shares at an average $0.82 ($8,200)
  20. 4 Open-market buy Director bought 15,000 shares at an average $0.76 ($11,450)

Page 3 of 44 · 870 filings